Virtuoso Therapeutics to present at AACR annual meeting

By The Science Advisory Board staff writers

March 28, 2022 -- Virtuoso Therapeutics will present two posters at the American Association for Cancer Research (AACR) 2022 annual meeting. The posters will highlight the company's preclinical data from its leading bispecific antibody programs, the company said.

The poster, "Multiple modes of action of the CD38 x ICAM-1 bispecific antibody" (5385), will be presented on Friday, April 8, 12-1 p.m. CT. The other poster, "CD47 x ICAM-1 bispecific antibody represents a novel approach for treating ICAM-1 overexpressing tumors" (3430) will be presented on Tuesday, April 12, 1:30-5 p.m. CT.

Copyright © 2022

BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter